• English
    • svenska
  • svenska 
    • English
    • svenska
  • Logga in
Redigera dokument 
  •   Startsida
  • Student essays / Studentuppsatser
  • Graduate School
  • Master theses
  • Redigera dokument
  •   Startsida
  • Student essays / Studentuppsatser
  • Graduate School
  • Master theses
  • Redigera dokument
JavaScript is disabled for your browser. Some features of this site may not work without it.

Bringing 3D Bioprinting to the Market; Agile marketing, rapid product development and strategic alliances

Sammanfattning
3D bioprinting technology is an emerging technology with a potential to revolutionize the medical field as it has a capability to biofabricate living tissue and organs using a patient’s own cells in conjunction with different biomaterials. This disruptive technology is in an early stage and innovators and early adopters stepwise improve the performance of the technology as it continuously grow. The first official 3D bioprinting company, Organovo from the USA, found their niche market in providing pharmaceutical companies with human tissue on demand that can be used for drug screening applications. This thesis describes a novel model used for bringing 3D bioprinting to the market, disrupting the current market established by Organovo. CELLINK AB, which is the first company in the world to commercialize a universal bioink for bioprinting of human tissue, has realized that successful commercialization stems from the creation of a system of products, rather than single products. Such system includes the commercialization of 3D Bioprinters, bioinks, consumables, and even bioprinting services for educational use. Providing bioprinters and bioink require, however, that the demand for such goods and services grows simultaneously. The strategic alliances with material suppliers and partnership with cell supplier played an important role in paving the path to market for CELLINK. The missing link, such as lack of CAD files of human tissue and organs, has been filled by creating an open source community, namely “Bioverse”. CELLINK, a start-up company found their niche by becoming the first 3D bioprinting company in the word that provides the whole introduction package to 3D bioprinting for innovators and early adopters. Agile marketing, rapid product development and strategic alliances were keys to CELLINK’s success. CELLINK is currently positioned in a rapid expansion stage and must focus heavily on R&D, sales and marketing to maintain its market shares and continue the growth. The following case study is an analysis using the Knowledge Intensive Entrepreneurship, KIE conceptual model (McKelvey, Lassen, 2013).
Examinationsnivå
Master 2-years
URL:
http://hdl.handle.net/2077/50630
Samlingar
  • Master theses
Fil(er)
gupea_2077_50630_1.pdf (7.645Mb)
Datum
2016-12-19
Författare
Gatenholm, Erik
Nyckelord
3D Bioprinting
CELLINK
Agile Marketing
Strategic Alliances
Disruptive Technology
Serie/rapportnr.
Master Degree Project
2016:51
Språk
eng
Metadata
Visa fullständig post

DSpace software copyright © 2002-2016  DuraSpace
gup@ub.gu.se | Teknisk hjälp
Theme by 
Atmire NV
 

 

Visa

VisaSamlingarI datumordningFörfattareTitlarNyckelordDenna samlingI datumordningFörfattareTitlarNyckelord

Mitt konto

Logga inRegistrera dig

DSpace software copyright © 2002-2016  DuraSpace
gup@ub.gu.se | Teknisk hjälp
Theme by 
Atmire NV